HOME >> BIOLOGY >> NEWS
City rain run-off poses threat to coastal water users

Rainwater running off city roofs and streets poses health risks to surfers and others who spend time in coastal waters, according to a new study.

Spending more time in the surf increased risk of fever, stomach pain, vomiting, diarrhea, skin infection, eye redness and other symptoms, according to the report in the American Journal of Public Health.

"These potential health risks warrant greater public health surveillance, as well as greater efforts to reduce pollutants discharged onto public beaches," say Ryan Dwight, Ph.D., and Dean B. Baker, M.D., M.P.H., of the University of California, Irvine, and colleagues.

The researchers interviewed surfers in 1998 and 1999 at two California beaches. One was North Orange County, whose watershed is one of the most developed in the world and which produces highly polluted runoff water. The other was in rural Santa Cruz County, which is farther north, less urbanized and less polluted.

"Surfers were selected as the study population because of their regular exposure to coastal waters," Baker says. In all, they interviewed 1,873 participants, asking about any illness symptoms they had experienced over the previous three months.

They also compared rainfall at the two beaches in each year and used local health department data to get coliform bacteria counts, a water pollution measure. Santa Cruz County had higher total rainfall each year compared to North Orange County, yet the latter had higher water coliform counts.

As it happened, California experienced record high precipitation in the winter of 1998, thanks to the El Nio effect. Surfers in North Orange County that year reported almost twice as many symptoms and higher rates of every symptom than those in Santa Cruz County.

By contrast, the winter of 1999 saw the opposite climate pattern, called the La Nia effect, which caused record low precipitation. Drier conditions that year produced only sli
'"/>

Contact: Dean B. Baker
dbaker@uci.edu
949-824-8641
Center for the Advancement of Health
31-Mar-2004


Page: 1 2

Related biology news :

1. Is run-off wrecking the Great Barrier Reef
2. New system developed for removing contaminants from storm run-off
3. Urban runoff poses increased health threat for surfers, other beach users, UCI study shows
4. UK Government proposes long-term strategy for science
5. Gene predisposes infants to neurologic injury after heart surgery
6. Scientist proposes new theory of aging
7. UCI biologist proposes trimming some branches
8. Deadly coral toxin exposes ion pumps deepest secret
9. Sequenced malaria genome exposes novel drug targets
10. UB study finds early nutritional modification programs metabolism, predisposes to obesity
11. Unique genetic alteration in presenilin 1 gene predisposes some Caribbean Hispanics to early-onset Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: City rain run off poses threat coastal water users

(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a ... and services, and Morpho, a leading supplier of ... to produce the market,s most advanced biometrically-enabled time ... iSolved NXG time clock is setting a bold, ... labor data for the small and mid-size employer. ...
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
(Date:4/16/2015)... (PRWEB) April 16, 2015 Regis Technologies ... American Association for Cancer Research (AACR) annual meeting. Regis ... Convention Center, starting Saturday, April 18, in Philadelphia and ... claim to title of the oldest and largest organization ... fellowships and grants, and partners with survivors to promote ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 ... at Charlotte (UNC Charlotte) spin-out company, announced today ... Cooper, Ph.D., M.D., as Chief Operating Officer (COO). ... of experience in developing clinical diagnostic and biotechnology ... infectious disease. , Cooper’s extensive career transcends the ...
(Date:4/16/2015)... 16, 2015  In recognition of World Hemophilia Day, ... groups to illuminate more than 15 prominent landmarks red throughout ... Boston,s Zakim Bridge and Prudential Tower, ... Mercedes-Benz Superdome and Denver,s ... of April 17, and coincide with hemophilia community events in ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:Regis Technologies Joins American Association for Cancer Research Annual Meeting 2OncoTAb Names Dr. David L. Cooper as COO 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
Cached News: